Baxter International Stock Price, News & Analysis (NYSE:BAX)

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 16th. Stockholders of record on Friday, August 30th will be given a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, August 29th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has approved a share buyback plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.08. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Baxter International updated its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $3.34-3.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.33. The company issued revenue guidance of $11.24-11.35 billion, compared to the consensus revenue estimate of $11.23 billion.

15 brokers have issued 12-month price targets for Baxter International's stock. Their predictions range from $70.00 to $95.00. On average, they anticipate Baxter International's stock price to reach $85.2143 in the next twelve months. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Press coverage about BAX stock has trended negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Baxter International.

Baxter International saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 5,609,800 shares, an increase of 30.6% from the July 31st total of 4,295,200 shares. Based on an average daily trading volume, of 2,240,000 shares, the days-to-cover ratio is currently 2.5 days. Approximately 1.1% of the company's stock are sold short. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Insulet (PODD), ABIOMED (ABMD), Novocure (NVCR), Hill-Rom (HRC), Haemonetics (HAE), Penumbra (PEN) and Integra Lifesciences (IART).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Johnson & Johnson (JNJ), Chipotle Mexican Grill (CMG), Honeywell International (HON), Micron Technology (MU), Cisco Systems (CSCO), Pfizer (PFE) and Allergan (AGN).

Baxter International's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.95%), BlackRock Inc. (7.95%), Vanguard Group Inc. (7.28%), Third Point LLC (4.50%), Morgan Stanley (3.36%) and Northern Trust Corp (1.72%). Company insiders that own Baxter International stock include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Price T Rowe Associates Inc. MD, AQR Capital Management LLC, Virginia Retirement Systems ET AL, Schroder Investment Management Group, Vanguard Group Inc., Anchor Capital Advisors LLC and Eaton Vance Management. Company insiders that have sold Baxter International company stock in the last year include Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, Balyasny Asset Management LLC, Morgan Stanley, Prudential PLC, Prudential Financial Inc., First Trust Advisors LP and Investec Asset Management LTD. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $87.40.

Baxter International has a market capitalization of $44.62 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]